2019

Pharmacotherapeutics Targeting the Hedgehog Pathway: Emerging Treatments for Metastatic Basal Cell Carcinoma

Visit USCO

Text Registration

Pharmacotherapeutics Targeting the Hedgehog Pathway: Emerging Treatments for Metastatic Basal Cell Carcinoma

Status

Published

on 14 Mar 2019

Year of Creation

2018

John-Mark Unsworth

Registration Number

TX0008691898

on 14 Mar 2019

The U.S. Copyright record (Registration Number: TX0008691898) dated 14 Mar 2019, pertains to an electronic file (eService) titled "Pharmacotherapeutics Targeting the Hedgehog Pathway: Emerging Treatments for Metastatic Basal Cell Carcinoma" created in 2018. The copyright holder is John-Mark Unsworth, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to John-Mark Unsworth.

John-Mark Unsworth

Application Details

Registration Number

TX0008691898

Registration Date

3/14/2019

Year of Creation

2018

Agency Marc Code

DLC-CO

Record Status

New

Physical Description

Electronic file (eService)

First Publication Nation

United States

Personal Authors

John-Mark Unsworth

Notes

Rights Note: Mark Dill, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com

Statements

Application Title Statement: Pharmacotherapeutics Targeting the Hedgehog Pathway: Emerging Treatments for Metastatic Basal Cell Carcinoma

Author Statement: John-Mark Unsworth Citizenship: not known Authorship: text

Notes

Rights Note: Mark Dill, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com

Statements

Application Title Statement: Pharmacotherapeutics Targeting the Hedgehog Pathway: Emerging Treatments for Metastatic Basal Cell Carcinoma

Author Statement: John-Mark Unsworth Citizenship: not known Authorship: text

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.